Selected research
Market Outlook & Growth Opportunities
Global Diammonium Glycyrrhizinate Capsules Market Outlook and Growth Opportunities 2026
Market perspective
The global Diammonium Glycyrrhizinate Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Diammonium Glycyrrhizinate Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Diammonium Glycyrrhizinate Capsules market include Chia Tai Tianqing Pharmaceutical, Suzhou Erye Pharmaceutical, Sichuan Shenghe Pharmaceutical, Shanxi Tongda Pharmaceutical and China Resources Double-Crane Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Diammonium Glycyrrhizinate Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diammonium Glycyrrhizinate Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diammonium Glycyrrhizinate Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diammonium Glycyrrhizinate Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Diammonium Glycyrrhizinate Capsules Segment by Company
Chia Tai Tianqing Pharmaceutical
Suzhou Erye Pharmaceutical
Sichuan Shenghe Pharmaceutical
Shanxi Tongda Pharmaceutical
China Resources Double-Crane Pharmaceutical
Diammonium Glycyrrhizinate Capsules Segment by Type
Original Drug
Generic Drug
Diammonium Glycyrrhizinate Capsules Segment by Application
Hospital
Clinic
Others
Diammonium Glycyrrhizinate Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Diammonium Glycyrrhizinate Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Diammonium Glycyrrhizinate Capsules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Diammonium Glycyrrhizinate Capsules significant trends, drivers, influence factors in global and regions.
6. To analyze Diammonium Glycyrrhizinate Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Diammonium Glycyrrhizinate Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diammonium Glycyrrhizinate Capsules industry.
Chapter 3: Detailed analysis of Diammonium Glycyrrhizinate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Diammonium Glycyrrhizinate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Diammonium Glycyrrhizinate Capsules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Clinic
- Others
Companies covered
- Chia Tai Tianqing Pharmaceutical
- Suzhou Erye Pharmaceutical
- Sichuan Shenghe Pharmaceutical
- Shanxi Tongda Pharmaceutical
- China Resources Double-Crane Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 1.2.2 Global Diammonium Glycyrrhizinate Capsules Sales Volume (2021-2032)
- 1.2.3 Global Diammonium Glycyrrhizinate Capsules Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Diammonium Glycyrrhizinate Capsules Market Dynamics
- 2.1 Diammonium Glycyrrhizinate Capsules Industry Trends
- 2.2 Diammonium Glycyrrhizinate Capsules Industry Drivers
- 2.3 Diammonium Glycyrrhizinate Capsules Industry Opportunities and Challenges
- 2.4 Diammonium Glycyrrhizinate Capsules Industry Restraints
3 Diammonium Glycyrrhizinate Capsules Market by Company
- 3.1 Global Diammonium Glycyrrhizinate Capsules Company Revenue Ranking in 2025
- 3.2 Global Diammonium Glycyrrhizinate Capsules Revenue by Company (2021-2026)
- 3.3 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Company (2021-2026)
- 3.4 Global Diammonium Glycyrrhizinate Capsules Average Price by Company (2021-2026)
- 3.5 Global Diammonium Glycyrrhizinate Capsules Company Ranking (2024-2026)
- 3.6 Global Diammonium Glycyrrhizinate Capsules Company Manufacturing Base and Headquarters
- 3.7 Global Diammonium Glycyrrhizinate Capsules Company Product Type and Application
- 3.8 Global Diammonium Glycyrrhizinate Capsules Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Diammonium Glycyrrhizinate Capsules Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Diammonium Glycyrrhizinate Capsules Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Diammonium Glycyrrhizinate Capsules Market by Type
- 4.1 Diammonium Glycyrrhizinate Capsules Type Introduction
- 4.1.1 Original Drug
- 4.1.2 Generic Drug
- 4.2 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Type
- 4.2.1 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Type (2021-2032)
- 4.2.3 Global Diammonium Glycyrrhizinate Capsules Sales Volume Share by Type (2021-2032)
- 4.3 Global Diammonium Glycyrrhizinate Capsules Sales Value by Type
- 4.3.1 Global Diammonium Glycyrrhizinate Capsules Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Diammonium Glycyrrhizinate Capsules Sales Value by Type (2021-2032)
- 4.3.3 Global Diammonium Glycyrrhizinate Capsules Sales Value Share by Type (2021-2032)
5 Diammonium Glycyrrhizinate Capsules Market by Application
- 5.1 Diammonium Glycyrrhizinate Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Application
- 5.2.1 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Diammonium Glycyrrhizinate Capsules Sales Volume by Application (2021-2032)
- 5.2.3 Global Diammonium Glycyrrhizinate Capsules Sales Volume Share by Application (2021-2032)
- 5.3 Global Diammonium Glycyrrhizinate Capsules Sales Value by Application
- 5.3.1 Global Diammonium Glycyrrhizinate Capsules Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Diammonium Glycyrrhizinate Capsules Sales Value by Application (2021-2032)
- 5.3.3 Global Diammonium Glycyrrhizinate Capsules Sales Value Share by Application (2021-2032)
6 Diammonium Glycyrrhizinate Capsules Regional Sales and Value Analysis
- 6.1 Global Diammonium Glycyrrhizinate Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Diammonium Glycyrrhizinate Capsules Sales by Region (2021-2032)
- 6.2.1 Global Diammonium Glycyrrhizinate Capsules Sales by Region: 2021-2026
- 6.2.2 Global Diammonium Glycyrrhizinate Capsules Sales by Region (2027-2032)
- 6.3 Global Diammonium Glycyrrhizinate Capsules Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Diammonium Glycyrrhizinate Capsules Sales Value by Region (2021-2032)
- 6.4.1 Global Diammonium Glycyrrhizinate Capsules Sales Value by Region: 2021-2026
- 6.4.2 Global Diammonium Glycyrrhizinate Capsules Sales Value by Region (2027-2032)
- 6.5 Global Diammonium Glycyrrhizinate Capsules Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 6.6.2 North America Diammonium Glycyrrhizinate Capsules Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 6.7.2 Europe Diammonium Glycyrrhizinate Capsules Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Diammonium Glycyrrhizinate Capsules Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 6.9.2 South America Diammonium Glycyrrhizinate Capsules Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Diammonium Glycyrrhizinate Capsules Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Diammonium Glycyrrhizinate Capsules Sales Value Share by Country, 2025 VS 2032
7 Diammonium Glycyrrhizinate Capsules Country-level Sales and Value Analysis
- 7.1 Global Diammonium Glycyrrhizinate Capsules Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Diammonium Glycyrrhizinate Capsules Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2032)
- 7.3.1 Global Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2026)
- 7.3.2 Global Diammonium Glycyrrhizinate Capsules Sales by Country (2027-2032)
- 7.4 Global Diammonium Glycyrrhizinate Capsules Sales Value by Country (2021-2032)
- 7.4.1 Global Diammonium Glycyrrhizinate Capsules Sales Value by Country (2021-2026)
- 7.4.2 Global Diammonium Glycyrrhizinate Capsules Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.9.2 France Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.16.2 China Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.19.2 India Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Diammonium Glycyrrhizinate Capsules Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Diammonium Glycyrrhizinate Capsules Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Diammonium Glycyrrhizinate Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Chia Tai Tianqing Pharmaceutical
- 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
- 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 8.1.3 Chia Tai Tianqing Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Chia Tai Tianqing Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 8.2 Suzhou Erye Pharmaceutical
- 8.2.1 Suzhou Erye Pharmaceutical Company Information
- 8.2.2 Suzhou Erye Pharmaceutical Business Overview
- 8.2.3 Suzhou Erye Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Suzhou Erye Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.2.5 Suzhou Erye Pharmaceutical Recent Developments
- 8.3 Sichuan Shenghe Pharmaceutical
- 8.3.1 Sichuan Shenghe Pharmaceutical Company Information
- 8.3.2 Sichuan Shenghe Pharmaceutical Business Overview
- 8.3.3 Sichuan Shenghe Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Sichuan Shenghe Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.3.5 Sichuan Shenghe Pharmaceutical Recent Developments
- 8.4 Shanxi Tongda Pharmaceutical
- 8.4.1 Shanxi Tongda Pharmaceutical Company Information
- 8.4.2 Shanxi Tongda Pharmaceutical Business Overview
- 8.4.3 Shanxi Tongda Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Shanxi Tongda Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.4.5 Shanxi Tongda Pharmaceutical Recent Developments
- 8.5 China Resources Double-Crane Pharmaceutical
- 8.5.1 China Resources Double-Crane Pharmaceutical Company Information
- 8.5.2 China Resources Double-Crane Pharmaceutical Business Overview
- 8.5.3 China Resources Double-Crane Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Value and Gross Margin (2021-2026)
- 8.5.4 China Resources Double-Crane Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.5.5 China Resources Double-Crane Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Diammonium Glycyrrhizinate Capsules Value Chain Analysis
- 9.1.1 Diammonium Glycyrrhizinate Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Diammonium Glycyrrhizinate Capsules Sales Mode & Process
- 9.2 Diammonium Glycyrrhizinate Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Diammonium Glycyrrhizinate Capsules Distributors
- 9.2.3 Diammonium Glycyrrhizinate Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst